GSK stock falls as CDC shifts RSV vaccine recommendation

) are falling after a Centers for Disease Control and Prevention committee shifted its recommendation on Respiratory Syncytial Virus vaccination dosages.joins Morning Brief to break down this latest development for GSK and what the CDC announcement could mean for the company moving forward.So the based on the data that was presented to an advisory panel this week, the CDC and the advisory panel recommended that those that are older on the older side of, uh, the age gap for seniors.

We also saw Moderna drop on its results, showing much lower efficacy than the other two companies when it comes to protection over two seasons.Micron is still trending in the right direction: Analyst The clock is ticking as Boeing’s 32,000-strong union negotiates to ‘save the company from itself’—even if it takes a costly strike

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

GSK Drops as RSV Shot Suffers Fresh Blow With US RecommendationGSK Plc slumped after US health officials recommended restricting vaccination with its RSV shot to people who are older and more at risk in a move that could reduce the market for the UK drugmaker’s blockbuster vaccine.
Source: BNNBloomberg - 🏆 83. / 50 Read more »